The homogenization of the samples, protein measurements, electrophoresis, primary and secondary antibody incubation, and quantification were performed following our previously established protocols (Boknik et al. 2019 (link); Gergs et al. 2021 (link); Neumann et al. 2021a (link), 2021b (link)). The following primary antibodies were used: anti-phosphorylated troponin inhibitor (P-TnI; #4004, Cell Signaling Technology Europe, Leiden, Netherlands) and anti-calsequestrin (CSQ) used as loading control (#ab3516, Abcam, Cambridge, UK).
Free full text: Click here